To amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.

1/24/2025, 9:21 AM
Referred to the House Committee on Energy and Commerce.
Bill 119 hr 685, also known as the "Abortion Drug Safety Act of 2021," aims to amend the Federal Food, Drug, and Cosmetic Act to impose stricter regulations on abortion drugs. The bill seeks to prohibit the approval of new abortion drugs, as well as investigational use exemptions for these drugs. Additionally, the bill proposes to impose additional regulatory requirements on previously approved abortion drugs.

The main goal of this legislation is to enhance the safety and oversight of abortion drugs in the United States. Supporters of the bill argue that these measures are necessary to protect the health and well-being of women who choose to undergo medical abortions.

Critics of the bill, however, argue that it restricts access to safe and effective abortion care and interferes with a woman's right to make decisions about her own body. They also raise concerns about the potential impact of the bill on healthcare providers and patients. Overall, Bill 119 hr 685 is a controversial piece of legislation that has sparked debate among lawmakers, healthcare professionals, and advocacy groups. It remains to be seen how this bill will progress through the legislative process and what its ultimate impact will be on the regulation of abortion drugs in the United States.
Congress
119

Number
HR - 685

Introduced on
2025-01-23

# Amendments
0

Sponsors
+5

Cosponsors
+5

Status of Legislation

Bill Introduced
Introduced to House
House to Vote
Introduced to Senate
Senate to Vote

Purpose and Summary

Referred to the House Committee on Energy and Commerce.
Bill 119 hr 685, also known as the "Abortion Drug Safety Act of 2021," aims to amend the Federal Food, Drug, and Cosmetic Act to impose stricter regulations on abortion drugs. The bill seeks to prohibit the approval of new abortion drugs, as well as investigational use exemptions for these drugs. Additionally, the bill proposes to impose additional regulatory requirements on previously approved abortion drugs.

The main goal of this legislation is to enhance the safety and oversight of abortion drugs in the United States. Supporters of the bill argue that these measures are necessary to protect the health and well-being of women who choose to undergo medical abortions.

Critics of the bill, however, argue that it restricts access to safe and effective abortion care and interferes with a woman's right to make decisions about her own body. They also raise concerns about the potential impact of the bill on healthcare providers and patients. Overall, Bill 119 hr 685 is a controversial piece of legislation that has sparked debate among lawmakers, healthcare professionals, and advocacy groups. It remains to be seen how this bill will progress through the legislative process and what its ultimate impact will be on the regulation of abortion drugs in the United States.
Alternative Names
Official Title as IntroducedTo amend the Federal Food, Drug, and Cosmetic Act to prohibit the approval of new abortion drugs, to prohibit investigational use exemptions for abortion drugs, and to impose additional regulatory requirements with respect to previously approved abortion drugs, and for other purposes.

Comments

Recent Activity

Latest Action1/23/2025
Referred to the House Committee on Energy and Commerce.